Global Cattle Vaccine 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR012511850

Publication Date:

January 29, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Cattle Vaccine market size was valued at US$ 1720 million in 2024 and is forecast to a readjusted size of USD 2584 million by 2031 with a CAGR of 6.1% during review period.
Global core cattle vaccine manufacturers include Merck Animal Health and Zoetis etc. The Top 2 companies hold a share about 50%. India is the largest market, with a share about 22%, followed by Brazil and North America with the share about 20% and 13%.
This report is a detailed and comprehensive analysis for global Cattle Vaccine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cattle Vaccine market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cattle Vaccine market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cattle Vaccine market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), 2020-2031
Global Cattle Vaccine market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cattle Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cattle Vaccine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Animal Health, Zoetis, Boehringer Ingelheim, Ceva, Jinyu Bio-Technology, CAHIC, TECON, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Cattle Vaccine market is split by Type and by Sales Channel. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Sales Channel. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Live Attenuated Vaccine
Inactivated Vaccine
Others
麻豆原创 segment by Sales Channel
Government Bidding
麻豆原创 Sales
麻豆原创 segment by players, this report covers
Merck Animal Health
Zoetis
Boehringer Ingelheim
Ceva
Jinyu Bio-Technology
CAHIC
TECON
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cattle Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cattle Vaccine, with revenue, gross margin, and global market share of Cattle Vaccine from 2020 to 2025.
Chapter 3, the Cattle Vaccine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Sales Channel, with consumption value and growth rate by Type, by Sales Channel, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cattle Vaccine market forecast, by regions, by Type and by Sales Channel, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cattle Vaccine.
Chapter 13, to describe Cattle Vaccine research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Cattle Vaccine by Type
1.3.1 Overview: Global Cattle Vaccine 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Cattle Vaccine Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Live Attenuated Vaccine
1.3.4 Inactivated Vaccine
1.3.5 Others
1.4 Global Cattle Vaccine 麻豆原创 by Sales Channel
1.4.1 Overview: Global Cattle Vaccine 麻豆原创 Size by Sales Channel: 2020 Versus 2024 Versus 2031
1.4.2 Government Bidding
1.4.3 麻豆原创 Sales
1.5 Global Cattle Vaccine 麻豆原创 Size & Forecast
1.6 Global Cattle Vaccine 麻豆原创 Size and Forecast by Region
1.6.1 Global Cattle Vaccine 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Cattle Vaccine 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Cattle Vaccine 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Cattle Vaccine 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Cattle Vaccine 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Cattle Vaccine 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Cattle Vaccine 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Merck Animal Health
2.1.1 Merck Animal Health Details
2.1.2 Merck Animal Health Major Business
2.1.3 Merck Animal Health Cattle Vaccine Product and Solutions
2.1.4 Merck Animal Health Cattle Vaccine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Merck Animal Health Recent Developments and Future Plans
2.2 Zoetis
2.2.1 Zoetis Details
2.2.2 Zoetis Major Business
2.2.3 Zoetis Cattle Vaccine Product and Solutions
2.2.4 Zoetis Cattle Vaccine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Zoetis Recent Developments and Future Plans
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Cattle Vaccine Product and Solutions
2.3.4 Boehringer Ingelheim Cattle Vaccine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
2.4 Ceva
2.4.1 Ceva Details
2.4.2 Ceva Major Business
2.4.3 Ceva Cattle Vaccine Product and Solutions
2.4.4 Ceva Cattle Vaccine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Ceva Recent Developments and Future Plans
2.5 Jinyu Bio-Technology
2.5.1 Jinyu Bio-Technology Details
2.5.2 Jinyu Bio-Technology Major Business
2.5.3 Jinyu Bio-Technology Cattle Vaccine Product and Solutions
2.5.4 Jinyu Bio-Technology Cattle Vaccine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Jinyu Bio-Technology Recent Developments and Future Plans
2.6 CAHIC
2.6.1 CAHIC Details
2.6.2 CAHIC Major Business
2.6.3 CAHIC Cattle Vaccine Product and Solutions
2.6.4 CAHIC Cattle Vaccine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 CAHIC Recent Developments and Future Plans
2.7 TECON
2.7.1 TECON Details
2.7.2 TECON Major Business
2.7.3 TECON Cattle Vaccine Product and Solutions
2.7.4 TECON Cattle Vaccine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 TECON Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Cattle Vaccine Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Cattle Vaccine by Company Revenue
3.2.2 Top 3 Cattle Vaccine Players 麻豆原创 Share in 2024
3.2.3 Top 6 Cattle Vaccine Players 麻豆原创 Share in 2024
3.3 Cattle Vaccine 麻豆原创: Overall Company Footprint Analysis
3.3.1 Cattle Vaccine 麻豆原创: Region Footprint
3.3.2 Cattle Vaccine 麻豆原创: Company Product Type Footprint
3.3.3 Cattle Vaccine 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Cattle Vaccine Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Cattle Vaccine 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Sales Channel
5.1 Global Cattle Vaccine Consumption Value 麻豆原创 Share by Sales Channel (2020-2025)
5.2 Global Cattle Vaccine 麻豆原创 Forecast by Sales Channel (2026-2031)
6 North America
6.1 North America Cattle Vaccine Consumption Value by Type (2020-2031)
6.2 North America Cattle Vaccine 麻豆原创 Size by Sales Channel (2020-2031)
6.3 North America Cattle Vaccine 麻豆原创 Size by Country
6.3.1 North America Cattle Vaccine Consumption Value by Country (2020-2031)
6.3.2 United States Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Cattle Vaccine Consumption Value by Type (2020-2031)
7.2 Europe Cattle Vaccine Consumption Value by Sales Channel (2020-2031)
7.3 Europe Cattle Vaccine 麻豆原创 Size by Country
7.3.1 Europe Cattle Vaccine Consumption Value by Country (2020-2031)
7.3.2 Germany Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Cattle Vaccine Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Cattle Vaccine Consumption Value by Sales Channel (2020-2031)
8.3 Asia-Pacific Cattle Vaccine 麻豆原创 Size by Region
8.3.1 Asia-Pacific Cattle Vaccine Consumption Value by Region (2020-2031)
8.3.2 China Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Cattle Vaccine Consumption Value by Type (2020-2031)
9.2 South America Cattle Vaccine Consumption Value by Sales Channel (2020-2031)
9.3 South America Cattle Vaccine 麻豆原创 Size by Country
9.3.1 South America Cattle Vaccine Consumption Value by Country (2020-2031)
9.3.2 Brazil Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Cattle Vaccine Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Cattle Vaccine Consumption Value by Sales Channel (2020-2031)
10.3 Middle East & Africa Cattle Vaccine 麻豆原创 Size by Country
10.3.1 Middle East & Africa Cattle Vaccine Consumption Value by Country (2020-2031)
10.3.2 Turkey Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Cattle Vaccine 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Cattle Vaccine 麻豆原创 Drivers
11.2 Cattle Vaccine 麻豆原创 Restraints
11.3 Cattle Vaccine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Cattle Vaccine Industry Chain
12.2 Cattle Vaccine Upstream Analysis
12.3 Cattle Vaccine Midstream Analysis
12.4 Cattle Vaccine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Merck Animal Health
Zoetis
Boehringer Ingelheim
Ceva
Jinyu Bio-Technology
CAHIC
TECON

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.